This receptor shift leads to dysregulated calcium influx and activation of Tau-related kinases such as GSK-3β and CDK5, which drive pathological phosphorylation at sites including Ser202/Thr205 and Ser396, commonly implicated in tauopathies [44,90,91]. The gene discussed is MAPT; the disease is tauopathy.